Andreas Reiter
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments 102
- Acute Myeloid Leukemia Research 39
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 94
- Chronic Lymphocytic Leukemia Research 25
- Rheumatology top 0.1%
- Eosinophilic Disorders and Syndromes 135
- Immunology top 1%
- Mast cells and histamine 60
-
- Lymphoma Diagnosis and Treatment 13
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 26
- Co-authors
- Nicholas C.P. CrossAndreas HochhausGeorgia MetzgerothAndrew ChaseJason GotlibRüdiger HehlmannAmy V. JonesKaterina Zoi
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Andreas Reiter
258 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Hematology 4.0k
- Genetics 3.4k
- Rheumatology 3.2k
- Immunology 1.6k
- Pathology and Forensic Medicine 802
Countries citing papers authored by Andreas Reiter
This map shows the geographic impact of Andreas Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Reiter more than expected).
Fields of papers citing papers by Andreas Reiter
This network shows the impact of papers produced by Andreas Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Reiter. The network helps show where Andreas Reiter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Reiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 10 | |
| 8 | 2021 | 29 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 4 | |
| 12 | COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110) | 2017 | 2 |
| 13 | 2015 | 44 | |
| 14 | Factors influencing the adoption of and business case for Cloud computing in the public sector | 2014 | 15 |
| 15 | 2013 | 80 | |
| 16 | 2012 | 21 | |
| 17 | 2010 | 39 | |
| 18 | 2009 | 56 | |
| 19 | 2005 | 54 | |
| 20 | Differential photoneutron cross sections of light nuclei for neutron dosimetry | 2004 | 1 |
About Andreas Reiter
Andreas Reiter is a scholar working on Hematology, Genetics and Rheumatology, having authored 278 papers that have together received 8.8k indexed citations. Recurring topics across this work include Eosinophilic Disorders and Syndromes (135 papers), Chronic Myeloid Leukemia Treatments (102 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (94 papers), Mast cells and histamine (60 papers), Acute Myeloid Leukemia Research (39 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (13 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (3.4k citations) and Rheumatology (3.2k citations). Andreas Reiter has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Nicholas C.P. Cross, Andreas Hochhaus, Georgia Metzgeroth, Andrew Chase, Jason Gotlib, Rüdiger Hehlmann, Amy V. Jones, Katerina Zoi, Francis Grand and Thomas Ernst. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, British Journal of Haematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.